Neuronasal
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2465 Citation Ct, Wexford, Pennsylvania,...Phone Number
(617) 714-3075Website
www.neuronasal.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Neuronasal
Neuronasal is focused on addressing critical medical needs through innovative treatments for Parkinson's Disease and Mild Traumatic Brain Injury. The company has developed a novel intranasal delivery method for the FDA-approved drug n-acetylcysteine (NAC), which has shown efficacy in clinical trials. Their unique approach allows for targeted drug delivery to specific brain regions, overcoming limitations of traditional dosing methods. Neuronasal aims to improve patient outcomes with its patented technology and is currently conducting Phase 1 clinical research funded by a STTR NIH/NIA grant.Explore more
Popular Searchesneuronasal LLCBrain Injury TreatmentNeuronasal IncNeuronasalSIC Code 28,283NAICS Code 32,325Show moreNeuronasal Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neuronasal your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Neuronasal had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Neuronasal has new funding data
Earning: See what the market has to say on Neuronasal recently announced quarterly report
Neuronasal, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Neuronasal has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Neuronasal
Product Launch: Get notified when Neuronasal launches new products
Check out if Neuronasal is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Neuronasal as Masked Content
Find 3 more new buyers
Compare Similar Companies to Neuronasal
Compare insights from companies similar to Neuronasal, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neuronasal is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neuronasal is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neuronasal.
Neuronasal Tech Stack
A closer look at the technologies used by Neuronasal
See more technologies
Neuronasal News & Media
ATAI Life Sciences Announces Neuronasal Completes Pilot Study, Receives IND Clearance to Continue into Phase I Trials of mTBI Therapeutic
NEW YORK, Oct. 27, 2020 /PRNewswire/ -- ATAI Life Sciences ("ATAI" or the "Company"), a global biotechnology company developing psychedelic and non-psychedelic compounds for various mental health indications, today announced that Neuronasal Inc. ("Neuronasal") has completed its pilot...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neuronasal
Sign Up For FreeTo access detailed company insights
Neuronasal is focused on addressing critical medical needs through innovative treatments for Parkinson's Disease and Mild Traumatic Brain Injury. The company has developed a novel intranasal delivery method for the FDA-approved drug n-acetylcysteine (NAC), which has shown efficacy in clinical trials. Their unique approach allows for targeted drug d... Read More
